Cognitive impairment in patients with cerebrovascular disease: A white paper from the links between stroke ESO Dementia Committee.
Stroke
cerebrovascular disease
cognitive impairment
dementia
small vessel disease
Journal
European stroke journal
ISSN: 2396-9881
Titre abrégé: Eur Stroke J
Pays: England
ID NLM: 101688446
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
01
02
2021
accepted:
04
02
2021
entrez:
5
4
2021
pubmed:
6
4
2021
medline:
6
4
2021
Statut:
ppublish
Résumé
Many daily-life clinical decisions in patients with cerebrovascular disease and cognitive impairment are complex. Evidence-based information sustaining these decisions is frequently lacking. The aim of this paper is to propose a practical clinical approach to cognitive impairments in patients with known cerebrovascular disease. The document was produced by the Dementia Committee of the European Stroke Organisation (ESO), based on evidence from the literature where available and on the clinical experience of the Committee members. This paper was endorsed by the ESO. Many patients with stroke or other cerebrovascular disease have cognitive impairment, but this is often not recognized. With improvement in acute stroke care, and with the ageing of populations, it is expected that more stroke survivors and more patients with cerebrovascular disease will need adequate management of cognitive impairment of vascular etiology. This document was conceived for the use of
Identifiants
pubmed: 33817330
doi: 10.1177/23969873211000258
pii: 10.1177_23969873211000258
pmc: PMC7995319
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
5-17Subventions
Organisme : Medical Research Council
ID : MR/L023784/2
Pays : United Kingdom
Informations de copyright
© European Stroke Organisation 2021.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Olivier Godefroy during the last five years has served on scientific advisory boards and speaker (Biogen, Astra Zeneca, Novartis) and received funding for travel and meetings from Bristol-Myers Squibb, Roche, Biogen, Teva-santé, Boehringer-Ingelheim, Covidien, Ipsen. The remaining authors declare that there are no conflict of interest concerning the paper.
Références
Lancet Neurol. 2009 Jul;8(7):643-53
pubmed: 19539236
Dev Psychol. 2015 May;51(5):573-82
pubmed: 25775112
Stroke. 2017 Jun;48(6):1539-1547
pubmed: 28487328
Stroke. 2011 Jun;42(6):1712-6
pubmed: 21474808
Cochrane Database Syst Rev. 2019 Mar 20;3:CD003154
pubmed: 30891742
Stroke. 2018 Apr;49(4):987-994
pubmed: 29581343
Nat Rev Dis Primers. 2018 Feb 15;4:18003
pubmed: 29446769
J Pharm Pract. 2018 Jun;31(3):322-334
pubmed: 28539102
BMC Neurol. 2016 Jul 26;16:115
pubmed: 27461245
Neuroepidemiology. 2017;49(3-4):129-134
pubmed: 29145207
Stroke. 2011 Sep;42(9):2672-713
pubmed: 21778438
Cerebrovasc Dis. 2013;36(5-6):355-62
pubmed: 24217342
Cerebrovasc Dis. 2009;27(5):502-8
pubmed: 19342826
Lancet Neurol. 2007 Sep;6(9):782-92
pubmed: 17689146
Lancet Neurol. 2008 Apr;7(4):310-8
pubmed: 18296124
Lancet Neurol. 2012 Nov;11(11):1006-12
pubmed: 23079557
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Neurology. 2016 Mar 22;86(12):1112-9
pubmed: 26888983
Radiographics. 2016 Sep-Oct;36(5):1426-47
pubmed: 27618323
Lancet Neurol. 2013 Aug;12(8):822-38
pubmed: 23867200
Lancet. 2015 Oct 24;386(10004):1698-706
pubmed: 26595643
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
Stroke. 2014 Oct;45(10):3008-18
pubmed: 25190446
Stroke. 2016 Jan;47(1):4-11
pubmed: 26578659
Neurology. 2011 Sep 27;77(13):1272-5
pubmed: 21917776
Dement Neuropsychol. 2019 Jan-Mar;13(1):31-43
pubmed: 31073378
Int J Stroke. 2015 Jun;10(4):627-35
pubmed: 24206541
J Alzheimers Dis. 2018;62(3):1417-1441
pubmed: 29562536
Neurology. 2019 Mar 19;92(12):e1298-e1308
pubmed: 30770431
Stroke. 2018 Feb;49(2):491-497
pubmed: 29335334
Geriatr Gerontol Int. 2015 Dec;15 Suppl 1:10-6
pubmed: 26671152
Int J Geriatr Psychiatry. 2019 Aug;34(8):1114-1127
pubmed: 31050033
Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):206-18
pubmed: 24632990
Int J Stroke. 2017 Dec;12(9):976-984
pubmed: 28355960
Continuum (Minneap Minn). 2019 Feb;25(1):147-164
pubmed: 30707191
Stroke. 2002 Sep;33(9):2243-6
pubmed: 12215594
J Neurol Neurosurg Psychiatry. 2007 Jan;78(1):56-9
pubmed: 16952914
Heart. 2014 Sep 15;100(18):1408-13
pubmed: 24951485
Int J Stroke. 2014 Apr;9(3):313-20
pubmed: 23227818
Stroke. 2006 Sep;37(9):2220-41
pubmed: 16917086
Psychol Med. 1994 Feb;24(1):145-53
pubmed: 8208879
Alzheimers Dement. 2015 Jan;11(1):16-23
pubmed: 24603162
Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1509-1525
pubmed: 29736698
Eur J Neurol. 2018 Sep;25(9):1182-1188
pubmed: 29782693
Stroke. 2017 Jan;48(1):180-186
pubmed: 27899749
Stroke. 2014 Jul;45(7):2160-236
pubmed: 24788967
Neurology. 2011 Nov 1;77(18):1664-73
pubmed: 22042795
Stroke. 1994 Nov;25(11):2220-6
pubmed: 7974549
Lancet Neurol. 2009 Nov;8(11):1006-18
pubmed: 19782001
Stroke. 2016 Feb;47(2):329-35
pubmed: 26683423
Stroke. 2013 Jan;44(1):138-45
pubmed: 23150656
Lancet Neurol. 2019 Mar;18(3):248-258
pubmed: 30784556
Nat Rev Neurol. 2017 Mar;13(3):148-159
pubmed: 28211452
Cochrane Database Syst Rev. 2018 Nov 01;11:CD011905
pubmed: 30383288
J Cereb Blood Flow Metab. 2016 Jan;36(1):6-25
pubmed: 26198175
Stroke. 2016 Oct;47(10):2645-8
pubmed: 27539301
Neurology. 1993 Feb;43(2):250-60
pubmed: 8094895
Lancet Neurol. 2017 Sep;16(9):730-740
pubmed: 28716371
J Alzheimers Dis. 2014;42 Suppl 3:S37-43
pubmed: 24898641
CMAJ. 2014 Oct 7;186(14):E536-46
pubmed: 25157064
J Neurol. 2019 Nov;266(11):2593-2604
pubmed: 30350168
J Alzheimers Dis. 2015;49(3):863-73
pubmed: 26529206
Stroke. 2018 Nov;49(11):2666-2673
pubmed: 30355190
Neurology. 2018 Nov 20;91(21):e1979-e1987
pubmed: 30333160
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
J Neurol Sci. 2014 Aug 15;343(1-2):176-9
pubmed: 24880539
Alzheimers Dement. 2017 Jun;13(6):624-633
pubmed: 27960092
Semin Neurol. 2019 Apr;39(2):241-250
pubmed: 30925616
N Engl J Med. 2003 Mar 27;348(13):1215-22
pubmed: 12660385
Stroke. 2013 Jun;44(6):1621-8
pubmed: 23652272
Neurol Sci. 2017 Jan;38(1):27-31
pubmed: 27699498
J Neurol. 2013 Jan;260(1):237-41
pubmed: 22865200
Neurology. 2011 May 3;76(18):1575-80
pubmed: 21451151
Neurology. 2016 Oct 25;87(17):1787-1795
pubmed: 27694265
Stroke. 2013 Sep;44(9):2427-33
pubmed: 23860300
PLoS One. 2016 Jul 25;11(7):e0159952
pubmed: 27454124
Biochim Biophys Acta. 2016 May;1862(5):869-77
pubmed: 26612719
Eur Stroke J. 2018 Jun;3(2):145-156
pubmed: 31008346
Brain. 2011 Dec;134(Pt 12):3716-27
pubmed: 22171356
BMC Neurol. 2017 May 23;17(1):102
pubmed: 28535786
Stroke. 2020 Mar;51(3):751-758
pubmed: 32070224
Lancet Neurol. 2019 Jul;18(7):653-665
pubmed: 31130428
Stroke. 2017 Jul;48(7):1842-1848
pubmed: 28596452
Cerebrovasc Dis. 2013;36(1):1-5
pubmed: 23899749
BMJ. 2009 Jul 06;339:b2477
pubmed: 19581317
Stroke. 2015 Oct;46(10):2874-80
pubmed: 26374482
Alzheimers Dement. 2016 Nov;12(11):1167-1176
pubmed: 27327542
Int J Stroke. 2012 Feb;7(2):183
pubmed: 22264374
Front Neurol. 2020 Jul 17;11:699
pubmed: 32765406
J Intern Med. 2004 Sep;256(3):240-6
pubmed: 15324367
Int Psychogeriatr. 2019 Nov;31(11):1655-1663
pubmed: 30782219
Dement Geriatr Cogn Disord. 2018;46(5-6):322-334
pubmed: 30504699
JAMA. 2015 May 19;313(19):1939-49
pubmed: 25988463
Stroke. 2017 Jan;48(1):98-104
pubmed: 27899753
J Stroke. 2018 May;20(2):228-238
pubmed: 29886723
Alzheimers Dement. 2016 Dec;12(12):1235-1249
pubmed: 27490018
Ther Adv Neurol Disord. 2012 Nov;5(6):349-58
pubmed: 23139705
Front Aging Neurosci. 2017 Oct 17;9:333
pubmed: 29089884
Neurology. 1997 May;48(5):1317-25
pubmed: 9153465
J Neurol Neurosurg Psychiatry. 1994 Feb;57(2):202-7
pubmed: 8126506
Neurology. 2015 Sep 1;85(9):776-82
pubmed: 26245928
Ann Neurol. 2016 Oct;80(4):581-92
pubmed: 27518166
Stroke. 2018 May;49(5):1141-1147
pubmed: 29643258
Alzheimers Dement (Amst). 2016 Nov 18;7:11-23
pubmed: 28138511